+Vote!
Fiercebiotech (Free subscription) | 12/01/2008
Earlier this year, Roche's plans to raise $45 billion to acquire the outstanding shares to Genentech looked like a simple transaction in the world of high finance. One global economic crisis and a few months later, though, and the bankers close to the money say that the breeze at Roche's back has turned into a gale-force headwind. Just days ago Roche reaffirmed that it is 100...
+Vote!
Politics.ie (Free subscription) | yesterday
I saw this story appear on RTE just under 24 hours ago and was holding my breath for a thread from someone on P.ie - I'm posting this up as it's on RTE.ie RTÉ News: Meath Council calls for Roche to resign Let's be careful with the auld libel, but there are clearly questions here that are neither being asked, nor answered.
+Vote!
Pharmalot (Free subscription) | yesterday
Those direct-to-consumer ads you see in the US have been a big mistake for the global drug industry, undermining the reputation of the sector in the eyes of patients, William Burns, who heads Roche’s pharmaceuticals group, tells a conference in London, according to Reuters. “Direct-to-consumer promotion was the single worst decision for the industry,” says Burns. [...]
1Vote!
Pharmalot (Free subscription) | 12/01/2008
The likelihood that Roche can raise a $45 billion syndicated loan to finance its proposed buyout of Genentech is becoming increasingly remote, bankers tells Reuters. The sheer size of the jumbo deal would eclipse today’s shrinking loan market, which senior banking sources say is putting pressure on Roche to consider alternative funding options, such as [...]
+Vote!
Captain Obvious (Free subscription) | 12/01/2008
You Should Know I've loved Aaron Roche's album Travel for a good while now thanks to my friend Ben's recommendation, and I was going to let him contribute an entry on Roche but he's partaking in a work/study program in Switzerland so I'd assume he has much better (and more picturesque) things to attend to than slapping together a write-up for CO. Hailing from Nashville, the multi-talented...
+Vote!
InformedTrades (Free subscription) | 12/01/2008
LONDON (Reuters) - The prospects of Swiss drugmaker Roche raising a $45 billion syndicated loan to finance the buyout of the rest of U.S. biotech...
+Vote!
Reuters UK (Free subscription) | 12/01/2008
LONDON (Reuters) - The prospects of Swiss drugmaker Roche raising a $45 billion (29.3 billion pound) syndicated loan to finance the buyout of the rest of U.S. biotech group Genentech are becoming increasingly remote.
+Vote!
Reuters (Free subscription) | 12/01/2008
LONDON (Reuters) - The prospects of Swiss drugmaker Roche raising a $45 billion syndicated loan to finance the buyout of the rest of U.S. biotech group Genentech are becoming increasingly remote.
+Vote!
Contract Pharma Breaking News (Free subscription) | 11/25/2008
Roche and Memory Pharmaceuticals have signed a definitive merger agreement under which Roche will acquire Memory Pharmaceuticals for $50 million in cash. Memory develops drug candidates for the treatment of central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company's nicotinic alpha-7 agonist drug candidates in these disease areas—currently being...
+Vote!
Cupcakes Take the Cake (Free subscription) | 11/26/2008
This is a wonderful idea, and I am hoping the baker/photographer will send us the recipe. Cupcakes filled with confection chocolate Ferrero Roche . Mmm...thanks to my_amii on Flickr for the yumminess . You can see the prebaked version here . I wonder how these would work with the coconut-almond white-chocolate Raffaello?
+Vote!
Fiercebiotech (Free subscription) | 11/25/2008
Roche is buying Memory Pharmaceuticals for $50 million. The pharma giant is paying 61 cents a share, a big premium over Memory's bottom-dwelling price of 15 cents a share. For Roche, it's a chance to buy experimental therapies for Alzheimer's and schizophrenia. The two companies are also already partnered on a mid-stage drug program. "The innovative work carried out by the scientists...
+Vote!
Politics.ie (Free subscription) | 11/26/2008
Ireland's minister for European affairs, Dick Roche, told the Czech CTK news agency that a second referendum on the Lisbon treaty is "inevitable,"...
+Vote!
The Star-Ledger (Free subscription) | 11/25/2008
Roche today said it plans to buy Memory Pharmaceuticals, its partner on a potential treatment for Alzheimer's disease, for $50 million. Memory had been forced to cut more than half its staff earlier this year, and faced delisting from Nasdaq...
+Vote!
McDuff's Food & Wine Trail (Free subscription) | 11/25/2008
... California Cab, what I opted for instead was Cabernet of a different ilk. Touraine Cabernet, Clos Roche Blanche 2006 $17. 12.5% alcohol. Nomacorc. Importer: Louis/Dressner, New York, NY. The label image above is borrowed from the 2005 vintage and Mike wrote-up the 2007. I went with the 2006, which just happened to be hanging out at home, waiting its turn in line. This is cool climate Cabernet...
